MSB's tech is not a one disease wonder but many diseases wonder paradigm shift. That is the key difference. LOTS of approvals are on their way.
The simple reason for this is inflammation is behind many diseases' startup and progression. When you add healing properties as well then you have a real paradigm shift. This is on top of NIL adverse effects compared to current treatments or drugs. Doctors get shocked when treating patients for heart trouble to see a huge fall in deaths from strokes as well for the patients so treated. Reducing inflammation being the reason why. So then they open this up for study as well and on it goes. Each of these is 100's of billions of future revenue and 1000's if not millions of lives saved down the line.
1ronnie you are simply not comparing like with like.
